GIORGI, RICCARDO
GIORGI, RICCARDO
Universita' degli Studi di MILANO
Effect of body mass index on the timing of therapeutic drug monitoring—guided dalbavancin dosing in patients with osteoarticular infections
2025 D. Cattaneo, M. Fusi, C. Mariani, M. Passerini, L. Scandiffio, S. Birindelli, S. Merli, R. Giorgi, A. Gori, A. Dolci
Appropriateness of loading dose and TDM in patients treated with teicoplanin: a single-centre observational retrospective cohort study comparing single-daily and thrice-weekly regimens
2025 A.H. Behring, C. Mariani, M. Gerbi, M. Offer, M. Matone, D. Cattaneo, A. Giacomelli, M. Colaneri, R. Giorgi, S. Merli, S. Piconi, S. Antinori, A. Gori, M. Passerini
Therapeutic Drug Monitoring of Dalbavancin in Real Life: A Two-Year Experience
2024 D. Cattaneo, M. Fusi, M. Colaneri, C. Fusetti, C. Genovese, R. Giorgi, M. Matone, S. Merli, F. Petri, A. Gori
Neurobrucellosis Presenting with Motor Damage or Hearing Loss, and Use of Steroids are Associated with a Higher Risk of Sequelae or Relapse: A Systematic Review of Individual Participant Data
2024 C. Fusetti, F. Petri, M.H. Murad, S. Merli, R. Giorgi, G. Rizzardini, A. Gori, M. Passerini
Proactive therapeutic monitoring of dalbavancin concentrations in the long-term management of chronic osteoarticular/periprosthetic joint infections
2024 D. Cattaneo, M. Fusi, L. Galli, C. Genovese, R. Giorgi, M. Matone, S. Merli, M. Colaneri, A. Gori
Tinea Imbricata in an Italian Child and Review of the Literature
2015 S. Veraldi, R. Giorgi, P. Pontini, G. Tadini, G. Nazzaro
Fibrosis progression in paired liver biopsies from HIV/HCV co-infected patients
2011 M. Schiavini, E. Angeli, A. Mainini, C. Uberti-Foppa, P. Zerbi, C. Sagnelli, A. Cargnel, G. Vago, P.G. Duca, R. Giorgi, G. Rizzardini, G. Gubertini